Shares of Synlogic, Inc. (NASDAQ:SYBX – Get Free Report) crossed above its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $1.09 and traded as high as $1.10. Synlogic shares last traded at $1.10, with a volume of 17,085 shares.
Synlogic Stock Up 6.8%
The company has a market cap of $13.47 million, a PE ratio of -4.23 and a beta of 0.70. The business has a 50-day simple moving average of $1.09 and a 200-day simple moving average of $0.84.
Synlogic (NASDAQ:SYBX – Get Free Report) last posted its quarterly earnings data on Tuesday, November 10th. The biotechnology company reported ($0.31) EPS for the quarter, beating analysts’ consensus estimates of ($5.80) by $5.49. On average, research analysts forecast that Synlogic, Inc. will post -2.71 EPS for the current fiscal year.
About Synlogic
Synlogic, Inc. was a clinical-stage biopharmaceutical company focused on developing medicines based on synthetic biology. Its platform used genetically engineered probiotic bacteria, known as Synthetic Biotics, designed to carry out specific therapeutic functions inside the gastrointestinal tract. The company’s research programs targeted metabolic and gastrointestinal disorders. Its leading candidates included SYNB1934, an investigational treatment intended to help break down phenylalanine in people with phenylketonuria, and SYNB8802, which was designed to consume oxalate in the gut for the potential treatment of enteric hyperoxaluria.
Further Reading
- Five stocks we like better than Synlogic
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Synlogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synlogic and related companies with MarketBeat.com's FREE daily email newsletter.
